诺思格2026年1月13日涨停分析：治理优化+业绩增长+资金运用

Group 1 - The core point of the article is that Norsg (sz301333) reached its daily limit up on January 13, 2026, with a price of 76.48 yuan, representing a 20.01% increase, and a total market capitalization of 7.387 billion yuan [1] Group 2 - The reasons for Norsg's limit up include governance optimization, performance growth, and effective capital utilization. The company announced a comprehensive governance structure optimization, including board structure adjustments and the addition of independent directors, which enhances decision-making and transparency [2] - The company utilized 140 million yuan of raised funds to supplement its working capital, improving capital efficiency and reducing financial costs, signaling good management and development prospects [2] - For Q3 2025, the company reported impressive operating performance with a revenue increase of 24.48%, net profit growth of 32.98%, and a 52.69% rise in non-recurring net profit, indicating strong business momentum [2] - As a provider of full-chain clinical research outsourcing services for global pharmaceutical and medical device companies, the company benefits from the growth of the pharmaceutical industry [2] - From a technical perspective, the stock may have attracted investor interest due to positive signals such as MACD crossovers and price breakthroughs, alongside a sector-wide positive performance [2]